Physicians need technology that helps them track disease progression and response to therapy.
One goal is to develop a fast, non-invasive way to evaluate skin rashes, such as ‘COVID toes’, for ischemia.
The adoption of accurate non-invasive measures of liver health at the point of care is critical.
The new method could help detect IBD, celiac disease, food allergies and other diseases much earlier.
A $10 million award from the National Science Foundation could help Rice University make this concept a reality.
The finger-prick alternative may help diabetic patients more effectively monitor their condition.